Cargando…

Candida auris‒Associated Hospitalizations, United States, 2017–2022

Using a large US hospital database, we describe 192 Candida auris‒associated hospitalizations during 2017–2022, including 38 (20%) C. auris bloodstream infections. Hospitalizations involved extensive concurrent conditions and healthcare use; estimated crude mortality rate was 34%. These findings und...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benedict, Kaitlin, Forsberg, Kaitlin, Gold, Jeremy A.W., Baggs, James, Lyman, Meghan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310363/ https://www.ncbi.nlm.nih.gov/pubmed/37347923 http://dx.doi.org/10.3201/eid2907.230540

Ejemplares similares

Candida auris screening practices at healthcare facilities in the United States: A survey of the Emerging Infections Network
por: Hennessee, Ian, et al.
Publicado: (2023)

Candida auris Whole-Genome Sequence Benchmark Dataset for Phylogenomic Pipelines
por: Welsh, Rory M., et al.
Publicado: (2021)

174. Increase in Candida auris cases in New Jersey healthcare facilities during the COVID-19 pandemic — 2017–2020
por: Magleby, Reed, et al.
Publicado: (2021)

Investigation of the first cluster of Candida auris cases among pediatric patients in the United States―Nevada, May 2022
por: Jones, Sophie, et al.
Publicado: (2023)

Low positivity rate and high percentage of nondermatophyte molds in an analysis of 35,257 fungal nail culture results from a United States national commercial laboratory, 2019-2022
por: Benedict, Kaitlin, et al.
Publicado: (2023)

Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020
por: Prestel, Christopher, et al.
Publicado: (2021)

Sporotrichosis-Associated Hospitalizations, United States, 2000–2013
por: Gold, Jeremy A.W., et al.
Publicado: (2016)

Candida auris in a U.S. Patient with Carbapenemase-Producing Organisms and Recent Hospitalization in Kenya
por: Brooks, Richard B., et al.
Publicado: (2019)

Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea—United States, 2022
por: Benedict, Kaitlin, et al.
Publicado: (2022)

Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017
por: Belkin, Ana, et al.
Publicado: (2018)

Possible misdiagnosis, inappropriate empiric treatment, and opportunities for increased diagnostic testing for patients with vulvovaginal candidiasis—United States, 2018
por: Benedict, Kaitlin, et al.
Publicado: (2022)

On the Origins of a Species: What Might Explain the Rise of Candida auris?
por: Jackson, Brendan R., et al.
Publicado: (2019)

Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings
por: Caceres, Diego H., et al.
Publicado: (2019)

Fluconazole resistance in non-albicans Candida species in the United States, 2012-2021
por: Jenkins, Emily, et al.
Publicado: (2023)

Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
por: Benedict, Kaitlin, et al.
Publicado: (2020)

161. Prevalence and Risk Factors for Candida auris Colonization Among Patients in a Long-term Acute Care Hospital—New Jersey, 2017
por: Rozwadowski, Faye, et al.
Publicado: (2018)

923. Rapid Emergence of Candida auris in the Chicago Region
por: Kerins, Janna L, et al.
Publicado: (2018)

High Frequency of Self-Diagnosis and Self-Treatment in a Nationally Representative Survey about Superficial Fungal Infections in Adults—United States, 2022
por: Benedict, Kaitlin, et al.
Publicado: (2022)

1268. Transmissibility of Candida auris by Type of Inpatient Healthcare Facility
por: Paul, Prabasaj, et al.
Publicado: (2018)

Health Care Utilization and Outcomes Associated with Accidental Poisonous Mushroom Ingestions — United States, 2016–2018
por: Gold, Jeremy A.W., et al.
Publicado: (2021)

Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020
por: Escandón, Patricia, et al.
Publicado: (2021)

Candida Auris: An Emerging Multidrug-Resistant Fungal Pathogen in the United States and the Urgent Call for Action
por: Kumar, Harendra, et al.
Publicado: (2023)

Blastomycosis-Associated Hospitalizations, United States, 2010–2020
por: Benedict, Kaitlin, et al.
Publicado: (2023)

Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021
por: Gold, Jeremy A.W., et al.
Publicado: (2023)

Skin Metagenomic Sequence Analysis of Early Candida auris Outbreaks in U.S. Nursing Homes
por: Huang, Xin, et al.
Publicado: (2021)

Candida auris Candidemia in Kuwait, 2014
por: Emara, Maha, et al.
Publicado: (2015)

Incursions of Candida auris into Australia, 2018
por: Lane, Courtney R., et al.
Publicado: (2020)

Colonization screening positivity rates for novel multidrug-resistant organism healthcare containment responses during 2019–2022
por: Rankin, Danielle, et al.
Publicado: (2023)

Notes from the Field: Transmission of Pan-Resistant and Echinocandin-Resistant Candida auris in Health Care Facilities ― Texas and the District of Columbia, January–April 2021
por: Lyman, Meghan, et al.
Publicado: (2021)

2449. Early Detection of Candida auris is Essential to Control Spread: Four Effective Active Surveillance Strategies
por: Vallabhaneni, Snigdha, et al.
Publicado: (2019)

Sporotrichosis Cases in Commercial Insurance Data, United States, 2012–2018
por: Benedict, Kaitlin, et al.
Publicado: (2020)

Outbreak of Candida auris infection in a COVID-19 hospital in Mexico
por: Villanueva-Lozano, Hiram, et al.
Publicado: (2021)

Candida auris–Associated Candidemia, South Africa
por: Magobo, Rindidzani E., et al.
Publicado: (2014)

Screening for Candida auris in patients admitted to eight intensive care units in England, 2017 to 2018
por: Sharp, Ashley, et al.
Publicado: (2021)

Alarming prevalence of Candida auris among critically ill patients in intensive care units in Dhaka City, Bangladesh
por: Chowdhury, Fahmida, et al.
Publicado: (2023)

Nationwide Outbreak of Candida auris Infections Driven by COVID-19 Hospitalizations, Israel, 2021–2022
por: Biran, Roni, et al.
Publicado: (2023)

Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
por: Ostrowsky, Belinda, et al.
Publicado: (2020)

Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017
por: Tsay, Sharon, et al.
Publicado: (2017)

Candida auris in Germany and Previous Exposure to Foreign Healthcare
por: Hamprecht, Axel, et al.
Publicado: (2019)

Potential Fifth Clade of Candida auris, Iran, 2018
por: Chow, Nancy A., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_228v7c6epa2ea436vh56ld5mba